| Title |
Oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease
|
|---|---|
| Published in |
International Journal of Chronic Obstructive Pulmonary Disease, November 2014
|
| DOI | 10.2147/copd.s41476 |
| Pubmed ID | |
| Authors |
Simon E Brill, Jadwiga A Wedzicha |
| Abstract |
Acute exacerbations of chronic obstructive pulmonary disease (COPD) are important events in the history of this debilitating lung condition. Associated health care utilization and morbidity are high, and many patients require supplemental oxygen or ventilatory support. The last 2 decades have seen a substantial increase in our understanding of the best way to manage the respiratory failure suffered by many patients during this high-risk period. This review article examines the evidence underlying supplemental oxygen therapy during exacerbations of COPD. We first discuss the epidemiology and pathophysiology of respiratory failure in COPD during exacerbations. The rationale and evidence underlying oxygen therapy, including the risks when administered inappropriately, are then discussed, along with further strategies for ventilatory support. We also review current recommendations for best practice, including methods for improving oxygen provision in the future. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 33% |
| Members of the public | 1 | 33% |
| Scientists | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 206 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| India | 1 | <1% |
| Sweden | 1 | <1% |
| Unknown | 203 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 56 | 27% |
| Student > Master | 25 | 12% |
| Student > Postgraduate | 16 | 8% |
| Researcher | 13 | 6% |
| Other | 12 | 6% |
| Other | 28 | 14% |
| Unknown | 56 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 71 | 34% |
| Nursing and Health Professions | 36 | 17% |
| Biochemistry, Genetics and Molecular Biology | 9 | 4% |
| Agricultural and Biological Sciences | 9 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 3% |
| Other | 18 | 9% |
| Unknown | 56 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 September 2021.
All research outputs
#6,496,106
of 25,374,647 outputs
Outputs from International Journal of Chronic Obstructive Pulmonary Disease
#717
of 2,577 outputs
Outputs of similar age
#66,721
of 273,826 outputs
Outputs of similar age from International Journal of Chronic Obstructive Pulmonary Disease
#7
of 28 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 2,577 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 273,826 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.